Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily bronchodilator inhalers versus tiotropium for exercise endurance in COPD
ISRCTN94574860Phase 4Suspended
- Sponsor
- Medical University of Białystok
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tiotropium, olodaterol, umeclidinium, vilanterol, indacaterol and 1 more in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Medical University of Białystok. Primary endpoint: Change in cycling endurance time. Started Mar 2024; status: suspended.
02
Drugs
tiotropiumolodaterolumeclidiniumvilanterolindacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ISRCTN94574860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN94574860.